IFI6 and esophageal squamous cell carcinoma: Consistent with the EdU assay results, treatment of ESCC cells with ROS inhibitors completely reversed IFI6 silencing-induced apoptosis (Fig. 4b, Figure S3B), which supported the role of ROS in the IFI6 silencing-induced reduction in cell viability.